Use of landiolol in the perioperative management of supraventricular tachycardia.
Ito
Hiroaki
H
Sobue
Kazuya
K
So
Minhye
M
Hirate
Hiroyuki
H
Sugiura
Takeshi
T
Azami
Takafumi
T
Sasano
Hiroshi
H
Katsuya
Hirotada
H
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002315:Cardiopulmonary Bypass; D002316:Cardiotonic Agents / Q000008:administration & dosage; D004298:Dopamine / Q000008:administration & dosage; D004437:Ebstein Anomaly / Q000601:surgery; D004554:Electric Countershock / Q000379:methods; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy / Q000209:etiology; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D019990:Perioperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000188:drug therapy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D016896:Treatment Outcome; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D009025:Morpholines; C077049:landiolol; D014508:Urea; D004298:Dopamine